If TFC can offload Santalis for a big cash profit....depends on outcome of multiple trials. The data in the JPM Healthcare conference presentation released to the ASX suggests a sale of Santalis could be worth $US300-=$US500m (80c-$1.40 per TFC share) based on other comparable transactions.
TFC Price at posting:
$1.46 Sentiment: Hold Disclosure: Held
